New Data Show Importance of Vectra® Testing and Biomarkers in Predicting Risk for Cardiovascular Events in Patients with Rheumatoid Arthritis

    NEXT STORY
    Black Diamond Therapeutics to Present at the Jefferies 2020 Virtual London Healthcare Conference
    PREV STORY
    G1 Therapeutics to Present at the Stifel Virtual Healthcare Conference on November 18, 2020
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    POINT Biopharma Announces Phase 3 Prostate Cancer Trial

    author_avatar
    NASDAQ Market News

    Relypsa Announces Results of Sub-Group Analyses from Phase 3 OPAL-HK Trial of Veltassa (patiromer) Presented at ASN Kidney Week 2015

    Veltassa significantly reduced and maintained control of blood potassium levels in OPAL-HK pre-specified sub-group ...

    author_avatar
    NASDAQ Market News

    Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies

    author_avatar
    NASDAQ Market News